A to collect blood biomarker samples from patients with Chronic Hepatitis B who 13/NTB/68 Approve received treatment with Pegasys Prof Edward Gane Auckland District Health Board Intervention (Peginterferon Alpha-2a) ±Nucleo(s)tide Analogue Can Acids in Combination with Exercise CCDHB,Sally Lark, Massey 13/NTB/69 Approve Training Improve Glycaemic Control and Mr Kim Gaffney Intervention University Cardiovascular Health in Type-2 Diabetics? A Clinical to test different doses of a 13/NTB/7 Approve new medication IPI145 given with Dr Kumar Research Office Intervention Methotrexate to treat Rheumatoid Arthritis Auckland District Health Dr Edmond Walford,Dr Board,CMDHB Research A to Evaluate Cardiovascular Outcomes Gordon Dean Office,G D Millar-Coote,Lipid & 13/NTB/71 Approve in Patients with Type 2 Diabetes Treated with Dr John Baker Jocelyne Intervention Diabetes Research Group,Prof ITCA 650 Benatar,Prof Russell Richard Stubbs, P3 Scott Research,Waitemata DHB Non high risk chest pain patients are safe for 13/NTB/72 Approve Dr Andrew Observational discharge A trial to determine if adding canagliflozin to Dr Dean Quinn,Dr metformin therapy is effective, safe and well G D Millar-Coote,Lakeland Jeremy Krebs,Dr 13/NTB/73 Decline tolerated in patients with Type 2 Diabetes Dr Michael Williams Clinical Trials,Prof Richard Intervention Gordon Dean Mellitus who are unable to control their blood Stubbs from P3 Research Ltd Coote sugar with die 13/NTB/76 Approve Treatment of Chronic Hepatitis B. Dr. William Abbott Observational 13/NTB/78 Approve Early Results of SUFE Treatment Mr Andrew Graydon Observational
13/NTB/68 Approve A to collect blood biomarker samples from patients with Chronic Hepatitis B who received treatment with Pegasys (Peginterferon Alpha-2a) ±Nucleo(s)tide Analogue Prof Edward Gane Auckland District Health Board Intervention 13/NTB/69 Approve Can Acids in Combination with Exercise Training Improve Glycaemic Control and Cardiovascular Health in Type-2 Diabetics? Mr Kim Gaffney CCDHB,Sally Lark, Massey University Intervention 13/NTB/7 Approve A Clinical to test different doses of a new medication IPI145 given with Methotrexate to treat Rheumatoid Arthritis Dr Kumar Research Office Intervention 13/NTB/71 Approve A to Evaluate Cardiovascular Outcomes in Patients with Type 2 Diabetes Treated with ITCA 650 Dr John Baker Dr Edmond Walford,Dr Gordon Dean Jocelyne Benatar,Prof Russell Scott Auckland District Health Board,CMDHB Research Office,G D Millar-Coote,Lipid & Diabetes Research Group,Prof Richard Stubbs, P3 Research,Waitemata DHB Intervention 13/NTB/72 Approve Non high risk chest pain patients are safe for discharge Dr Andrew Observational 13/NTB/73 Decline A to determine if adding canagliflozin to metformin therapy is effective, safe and well tolerated in patients with Type 2 Diabetes Mellitus who are unable to control their blood sugar with die Dr Michael Williams Dr Dean Quinn,Dr Jeremy Krebs,Dr Gordon Dean G D Millar-Coote,Lakeland Clinical Trials,Prof Richard Stubbs from P3 Research Ltd Intervention 13/NTB/76 Approve Treatment of Chronic Hepatitis B. Dr. William Abbott Observational 13/NTB/78 Approve Early Results of SUFE Treatment Mr Andrew Graydon Observational Coote trial
northern-b-ethics-committee-annual-report-2013.docx